Scientist, Inflammation at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • PhD or equivalent degree
  • At least 3 years of relevant post-graduate independent research or drug development experience in immunology, fibrotic and autoimmune diseases
  • Experience and knowledge in human fibrotic and inflammatory diseases, immunology research (preferred)
  • Top expertise in previous research areas
  • Critical analytical skills

Responsibilities

  • Design and execute human-relevant experiments in primary blood/tissue (gut, liver, skin, lung, synovium); perform responder vs non-responder comparisons, perturbation studies, and pathway/target validation
  • High-dimensional profiling: plan/execute high-parameter flow or mass cytometry (≥18-color), receptor occupancy and phospho-flow; single-cell (scRNA-seq/ATAC) and spatial transcriptomics/proteomics; multiplex IF/IHC and quantitative pathology
  • Endotype & biomarker strategy: define disease-agnostic PD/RO and endotype markers; qualify/validate fit-for-purpose assays (ELISA/MSD, qPCR/ddPCR, ligand-binding, RO/TE) and transfer to internal labs/CROs under GCLP
  • Sample strategy & operations: contribute to protocol/IB biomarker sections; specify pre-analytical handling, chain-of-custody and kitting; support CRO selection/oversight; ensure data integrity and timely delivery
  • Data integration & interpretation: partner with Biostats and Bioinformatics teams on analysis plans; integrate multi-omic/imaging and clinical data; craft succinct go/no-go narratives for governance
  • Influence without authority: coordinate across functions; document SOPs; contribute to safety/quality culture; mentor peers and have a growth mindset
  • Lead reverse translation workstreams: interrogate clinical/real-world datasets with Clinical, Biostats, and Bioinformatics; generate mechanistic hypotheses for response/non-response

Skills

Key technologies and capabilities for this role

biomarker discoverytranslational researchprimary human cellstissue assaysex vivo experimentsresponder analysisinflammation biologyfibrotic diseases

Questions & Answers

Common questions about this position

Is this position remote or lab-based?

The position is lab-based.

What salary or compensation does this role offer?

This information is not specified in the job description.

What key skills are required for the Scientist, Inflammation role?

Key skills include designing and executing experiments in primary blood/tissue, high-dimensional profiling using flow/mass cytometry, single-cell RNA-seq, spatial transcriptomics, and data integration with bioinformatics.

What is the company culture like at Gilead Sciences?

Gilead emphasizes collaboration, determination, and a relentless drive to make a difference, with a focus on creating an inclusive environment where employees feel developed and empowered through great leadership.

What makes a strong candidate for this research scientist position?

A strong candidate is talented, highly motivated, and able to contribute to translational research using state-of-the-art technologies in a collaborative, interdisciplinary team focused on fibrotic and inflammatory diseases.

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI